Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.
Schiffenbauer, Adam; Garg, Megha; Castro, Christine; Pokrovnichka, Angelina; Joe, Galen; Shrader, Joseph; Cabalar, Imelda Victoria; Faghihi-Kashani, Sara; Harris-Love, Michael O; Plotz, Paul H; Miller, Frederick W; Gourley, Mark.
Afiliación
  • Schiffenbauer A; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences. Electronic address: adam.schiffenbauer@nih.gov.
  • Garg M; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
  • Castro C; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
  • Pokrovnichka A; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
  • Joe G; Clinical Center, NIH, Department of Rehabilitation Medicine.
  • Shrader J; Clinical Center, NIH, Department of Rehabilitation Medicine.
  • Cabalar IV; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
  • Faghihi-Kashani S; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences.
  • Harris-Love MO; Clinical Center, NIH, Department of Rehabilitation Medicine.
  • Plotz PH; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
  • Miller FW; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences.
  • Gourley M; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
Semin Arthritis Rheum ; 47(6): 858-864, 2018 06.
Article en En | MEDLINE | ID: mdl-29174792
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Dermatológicos / Dermatomiositis / Infliximab / Inmunosupresores Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Semin Arthritis Rheum Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Dermatológicos / Dermatomiositis / Infliximab / Inmunosupresores Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Semin Arthritis Rheum Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos